Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

3.35USD
3:59pm EST
Change (% chg)

$0.09 (+2.76%)
Prev Close
$3.26
Open
$3.29
Day's High
$3.41
Day's Low
$3.29
Volume
87,743
Avg. Vol
105,464
52-wk High
$9.69
52-wk Low
$3.05

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.15 December 12 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.57 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 7.03 8.80 4.51 0.00
Quarter Ending Mar-19 2 6.25 6.70 5.80 --
Year Ending Dec-18 5 31.22 33.00 28.70 12.56
Year Ending Dec-19 5 23.79 31.00 12.00 11.97
Earnings (per share)
Quarter Ending Dec-18 5 -0.15 -0.12 -0.20 -0.12
Quarter Ending Mar-19 1 -0.18 -0.18 -0.18 --
Year Ending Dec-18 5 -0.47 -0.41 -0.56 -0.64
Year Ending Dec-19 5 -0.80 -0.62 -1.07 -0.74

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 7.41 8.35 0.94 12.68
Quarter Ending Jun-18 12.71 11.69 1.02 8.01
Quarter Ending Mar-18 10.83 4.15 6.68 61.65
Quarter Ending Dec-17 6.77 18.15 11.38 168.12
Quarter Ending Sep-17 1.05 3.93 2.88 274.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7.03 7.03 7.51 7.51 0.00
Quarter Ending Mar-19 6.25 6.25 6.25 5.80 --
Year Ending Dec-18 31.22 31.22 30.74 30.74 12.56
Year Ending Dec-19 23.79 23.79 22.57 22.57 11.97

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 1 2
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 3 1
Year Ending Dec-19 0 0 2 0
Earnings